Dr Reddys Laboratories Ltd
NSE :DRREDDY BSE :500124 Sector : PharmaceuticalsBuy, Sell or Hold DRREDDY? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
22 Mar 4474.95 (1.26%) | 21 Mar 4419.35 (-0.45%) | 20 Mar 4439.45 (0.07%) | 17 Mar 4436.15 (1.20%) | 16 Mar 4383.75 (-0.24%) | 15 Mar 4394.50 (1.03%) | 14 Mar 4349.55 (-0.48%) | 13 Mar 4370.40 (-0.57%) | 10 Mar 4395.55 (0.33%) | 09 Mar 4380.95 (-1.02%) | 08 Mar 4426.25 (-0.29%) | 06 Mar 4439.20 (0.03%) | 03 Mar 4437.95 (1.08%) | 02 Mar 4390.60 (1.07%) | 01 Mar 4344.20 (0.64%) | 28 Feb 4316.60 (-2.36%) | 27 Feb 4421.00 (-1.56%) | 24 Feb 4491.10 (0.93%) | 23 Feb 4449.60 (-0.61%) | 22 Feb 4476.70 (-0.21%) | 21 Feb 4486.15 (0.25%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Very Bullish
Moving Averages
5 DMA
Bullish
4431.02
10 DMA
Bullish
4406.32
20 DMA
Bullish
4412.53
50 DMA
Bullish
4396.85
100 DMA
Bullish
4398.66
200 DMA
Bullish
4344.17
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Mar 22, 2023 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 4562.16 | 4521.08 | 4492.59 | - | - |
R2 | 4521.08 | 4496.57 | 4486.71 | 4525.59 | - |
R1 | 4498.01 | 4481.44 | 4480.83 | 4507.03 | 4509.55 |
P | 4456.93 | 4456.93 | 4456.93 | 4461.44 | 4462.7 |
S1 | 4433.86 | 4432.42 | 4469.07 | 4442.88 | 4445.4 |
S2 | 4392.78 | 4417.29 | 4463.19 | 4397.29 | - |
S3 | 4369.71 | 4392.78 | 4457.31 | - | - |
Key Metrics
EPS
141.72
P/E
31.58
P/B
3.87
Dividend Yield
0.67%
Market Cap
74,520 Cr.
Face Value
5
Book Value
1156.21
ROE
11.84%
EBITDA Growth
2,002.2 Cr.
Debt/Equity
0.17
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Dr Reddys Laboratories Ltd Quaterly Results
Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | |
INCOME | 5412.6 | 5607.3 | 6096.2 | 6386.6 | 6854.5 |
PROFIT | 709.3 | 97 | 1189 | 1114.2 | 1243.9 |
EPS | 42.75 | 5.84 | 71.64 | 67.13 | 74.91 |
Dr Reddys Laboratories Ltd Quaterly Results
Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | |
INCOME | 3542.6 | 3783.4 | 4034 | 4998.3 | 3949 |
PROFIT | 341.1 | 419.7 | 499.5 | 1116.3 | 324.6 |
EPS | 20.55 | 25.29 | 30.1 | 67.25 | 19.54 |
Profit & Loss (Figures in Rs. Crores)
Dr Reddys Laboratories Ltd Profit & Loss
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | ||
INCOME | 12151 | 13904.6 | 15353.2 | 15959 | 14490.9 | 14477.7 | 16104.9 | 18170 | 20177.4 | 22453.8 | |
PROFIT | 1514.4 | 1945.62 | 2291.79 | 2071.62 | 1252.3 | 892.34 | 1849.63 | 2030.35 | 1954.44 | 2110.85 | |
EPS | 87.37 | 112.29 | 133.04 | 123.55 | 75.83 | 54.96 | 117.47 | 121.9 | 117.28 | 131.16 |
Dr Reddys Laboratories Ltd Profit & Loss
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | ||
INCOME | 8612.7 | 10050.1 | 10262.7 | 10645.6 | 10309.1 | 9614.9 | 10797.9 | 12693.5 | 14545.8 | 15276.8 | |
PROFIT | 1251.28 | 1926.89 | 1634.01 | 1320.26 | 1406.23 | 536.19 | 1274.22 | 2948.85 | 1849.38 | 1628.89 | |
EPS | 71.98 | 113.56 | 94.48 | 80.56 | 83.48 | 34.15 | 76.95 | 176.76 | 131.39 | 97.55 |
Balance Sheet (Figures in Rs. Crores)
Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 83.2 | 83.2 | 83.1 | 83 | 83 | 82.9 | 85.3 | 85.2 | 85.1 | 84.9 |
Reserves Total | 19,289.3 | 17,755.2 | 15,616.3 | 13,994.1 | 12,488.6 | 12,179.2 | 12,484.5 | 9,767.9 | 7,780.1 | 6,284.2 |
Equity Application Money | -160.1 | -196.7 | -100.6 | -53.5 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 19,212.4 | 17,641.7 | 15,598.8 | 14,023.6 | 12,571.6 | 12,262.1 | 12,569.8 | 9,853.1 | 7,865.2 | 6,369.1 |
Secured Loans | 0 | 0 | 178.7 | 60.9 | 69.3 | 70.7 | 85.7 | 86.2 | 104.7 | 88.2 |
Unsecured Loans | 3,384.5 | 3,030.8 | 2,031.5 | 3,777.2 | 5,002.1 | 4,847.8 | 3,266.4 | 4,227.9 | 4,372.3 | 3,594 |
Total Debt | 3,384.5 | 3,030.8 | 2,210.2 | 3,838.1 | 5,071.4 | 4,918.5 | 3,352.1 | 4,314.1 | 4,477 | 3,682.2 |
Other Liabilities | 192.7 | 212.5 | 280 | 297.4 | 375 | 427.6 | 344.5 | 351.2 | 174.4 | 86.4 |
Total Liabilities | 22,789.6 | 20,885 | 18,089 | 18,159.1 | 18,018 | 17,608.2 | 16,266.4 | 14,518.4 | 12,516.6 | 10,137.7 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 19,786.1 | 18,555.7 | 16,108.2 | 14,998.6 | 17,436.3 | 15,932.4 | 15,019.7 | 12,573.6 | 11,917.6 | 10,089.4 |
Less: Accumulated Depreciation | 11,664.6 | 10,350 | 9,257.9 | 7,807.6 | 10,468.3 | 9,001.7 | 8,456.7 | 7,196.6 | 7,276.8 | 6,038.8 |
Net Block | 8,121.5 | 8,205.7 | 6,850.3 | 7,191 | 6,968 | 6,930.7 | 6,563 | 5,377 | 4,640.8 | 4,050.6 |
Capital Work in Progress | 1,293.4 | 1,565.1 | 1,535.1 | 2,933.5 | 3,470.5 | 3,324.5 | 772.2 | 529 | 638.8 | 565.3 |
Investments | 2,615.9 | 2,211.8 | 2,677.8 | 2,587.1 | 2,298.3 | 2,109.7 | 3,833.1 | 2,247.8 | 1,066.8 | 197 |
Inventories | 5,088.4 | 4,541.2 | 3,506.7 | 3,357.9 | 2,908.9 | 2,852.8 | 2,557.9 | 2,569.9 | 2,418.8 | 2,170.7 |
Sundry Debtors | 6,676.4 | 4,964.1 | 5,027.8 | 3,986.9 | 4,052.7 | 3,798.6 | 4,125 | 4,101.2 | 3,325.3 | 3,180.4 |
Cash and Bank Balance | 2,419.2 | 2,078.8 | 205.3 | 222.8 | 263.8 | 386.5 | 492.1 | 1,872.4 | 2,300.6 | 2,017.1 |
Loans and Advances | 1,581 | 1,587.7 | 1,490.6 | 1,289.6 | 1,440 | 1,218.7 | 1,115.6 | 1,231 | 1,214.6 | 961.9 |
Total Current Assets | 15,765 | 13,171.8 | 10,230.4 | 8,857.2 | 8,665.4 | 8,256.6 | 8,290.6 | 9,774.5 | 9,259.3 | 8,330.1 |
Current Liabilities | 5,825.1 | 5,062.6 | 4,610.2 | 3,762.2 | 3,739.6 | 3,385.6 | 3,304.6 | 2,794.8 | 2,573.2 | 2,568.4 |
Provisions | 1,130.8 | 640.3 | 524.1 | 497 | 591.7 | 660.7 | 759.4 | 1,143.9 | 815.7 | 674.1 |
Total Current Liabilities & Provisions | 6,955.9 | 5,702.9 | 5,134.3 | 4,259.2 | 4,331.3 | 4,046.3 | 4,064 | 3,938.7 | 3,388.9 | 3,242.5 |
Net Current Assets | 8,809.1 | 7,468.9 | 5,096.1 | 4,598 | 4,334.1 | 4,210.3 | 4,226.6 | 5,835.8 | 5,870.4 | 5,087.6 |
Deferred Tax Assets | 1,277 | 1,068.6 | 1,219.9 | 431.7 | 540.5 | 678.4 | 590.5 | 260.5 | 191.7 | 174.2 |
Deferred Tax Liability | 1.4 | 28.9 | 2 | 47.3 | 195 | 162 | 53.7 | 156.2 | 124.1 | 107 |
Net Deferred Tax | 1,275.6 | 1,039.7 | 1,217.9 | 384.4 | 345.5 | 516.4 | 536.8 | 104.3 | 67.6 | 67.2 |
Other Assets | 674.1 | 393.8 | 711.8 | 465.1 | 601.6 | 516.6 | 334.7 | 424.5 | 232.2 | 170 |
Total Assets | 22,789.6 | 20,885 | 18,089 | 18,159.1 | 18,018 | 17,608.2 | 16,266.4 | 14,518.4 | 12,516.6 | 10,137.7 |
Contingent Liabilities | 0 | 0 | 0 | 138 | 277.57 | 102.17 | 92.17 | 190 | 221.6 | 112.6 |
Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 83.2 | 83.2 | 83.1 | 83 | 83 | 82.9 | 85.3 | 85.2 | 85.1 | 84.9 |
Reserves Total | 18,413.1 | 17,097.2 | 15,209.4 | 12,654.6 | 11,724.8 | 11,517.7 | 11,993.1 | 10,548.8 | 9,243.9 | 7,698.5 |
Equity Application Money | -160.1 | -196.7 | -100.6 | -53.5 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 18,336.2 | 16,983.7 | 15,191.9 | 12,684.1 | 11,807.8 | 11,600.6 | 12,078.4 | 10,634 | 9,329 | 7,783.4 |
Secured Loans | 0 | 0 | 19.3 | 0 | 0 | 0 | 0.9 | 1.4 | 1.7 | 4.7 |
Unsecured Loans | 2,205.4 | 1,214.5 | 1,437.6 | 1,064.6 | 2,588.8 | 2,355.2 | 3,084.2 | 3,124.7 | 2,664.5 | 2,095.3 |
Total Debt | 2,205.4 | 1,214.5 | 1,456.9 | 1,064.6 | 2,588.8 | 2,355.2 | 3,085.1 | 3,126.1 | 2,666.2 | 2,100 |
Other Liabilities | 94.6 | 67.9 | 84.1 | 83.2 | 84.6 | 103.4 | 123.6 | 75.3 | 38.2 | 32.6 |
Total Liabilities | 20,636.2 | 18,266.1 | 16,732.9 | 13,831.9 | 14,481.2 | 14,059.2 | 15,287.1 | 13,835.4 | 12,033.4 | 9,916 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 13,349.1 | 12,345 | 10,215.9 | 9,774.1 | 9,223.6 | 8,675.4 | 7,580 | 5,815.6 | 4,899.7 | 4,208.7 |
Less : Accumulated Depreciation | 7,198.6 | 6,500.7 | 5,782 | 5,091.4 | 4,506.3 | 3,833.3 | 3,141.9 | 2,566.2 | 2,151.4 | 1,821.7 |
Net Block | 6,150.5 | 5,844.3 | 4,433.9 | 4,682.7 | 4,717.3 | 4,842.1 | 4,438.1 | 3,249.4 | 2,748.3 | 2,387 |
Capital Work in Progress | 1,200.3 | 900.8 | 411.8 | 400.1 | 675 | 540 | 616.1 | 488.3 | 576.1 | 423.2 |
Investments | 4,936.7 | 4,649.2 | 5,485.5 | 3,933.5 | 3,636.5 | 3,101.9 | 5,076.1 | 3,862.3 | 2,806.5 | 2,379.2 |
Inventories | 3,347.8 | 2,819.7 | 2,190.4 | 2,015.6 | 1,856.8 | 1,809.7 | 1,699.6 | 1,723.3 | 1,592.1 | 1,526.5 |
Sundry Debtors | 4,945.4 | 4,080 | 4,638.7 | 3,717.7 | 4,203.8 | 4,405.4 | 3,889.5 | 4,711.7 | 4,561.5 | 2,963.9 |
Cash and Bank Balance | 2,030.5 | 1,646.5 | 39.2 | 113.2 | 120.7 | 66.8 | 202.1 | 901.4 | 665.1 | 919.1 |
Loans and Advances | 1,247.5 | 1,141 | 1,120 | 972.3 | 1,174.4 | 1,012.8 | 1,121.9 | 964.7 | 1,022.7 | 994.1 |
Total Current Assets | 11,571.2 | 9,687.2 | 7,988.3 | 6,818.8 | 7,355.7 | 7,294.7 | 6,913.1 | 8,301.1 | 7,841.4 | 6,403.6 |
Current Liabilities | 3,537.2 | 3,064.8 | 2,535.6 | 2,175.4 | 2,445.7 | 2,179.6 | 2,127.5 | 1,952.1 | 1,870 | 1,558 |
Provisions | 322.2 | 298.7 | 207.3 | 184.7 | 173.4 | 208.4 | 170.6 | 539.5 | 479.5 | 421.4 |
Total Current Liabilities & Provisions | 3,859.4 | 3,363.5 | 2,742.9 | 2,360.1 | 2,619.1 | 2,388 | 2,298.1 | 2,491.6 | 2,349.5 | 1,979.4 |
Net Current Assets | 7,711.8 | 6,323.7 | 5,245.4 | 4,458.7 | 4,736.6 | 4,906.7 | 4,615 | 5,809.5 | 5,491.9 | 4,424.2 |
Deferred Tax Assets | 440.7 | 582.1 | 867.3 | 214.1 | 346.5 | 382.8 | 306 | 35.7 | 23.1 | 32.5 |
Deferred Tax Liability | 421.3 | 327.3 | 254.4 | 269.6 | 253.4 | 300.7 | 242.5 | 164.7 | 148.3 | 126.2 |
Net Deferred Tax | 19.4 | 254.8 | 612.9 | -55.5 | 93.1 | 82.1 | 63.5 | -129 | -125.2 | -93.7 |
Other Assets | 617.5 | 293.3 | 543.4 | 412.4 | 622.7 | 586.4 | 478.3 | 554.9 | 535.8 | 396.1 |
Total Assets | 20,636.2 | 18,266.1 | 16,732.9 | 13,831.9 | 14,481.2 | 14,059.2 | 15,287.1 | 13,835.4 | 12,033.4 | 9,916 |
Contingent Liabilities | 0 | 0 | 0 | 316.2 | 305.37 | 102.17 | 92.17 | 1,231.9 | 1,605.2 | 1,740 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 3,061.4 |
Depreciation | 1,165.2 |
Interest (Net) | -0.7 |
P/L on Sales of Assets | -111.9 |
Prov. and W/O (Net) | 937.4 |
P/L in Forex | -75.8 |
Total Adjustments (PBT and Ext... | 1,875.4 |
Operating Profit before Workin... | 4,936.8 |
Trade and 0ther Receivables | -1,701.2 |
Inventories | -532.8 |
Trade Payables | 441.2 |
Total Adjustments (OP before W... | -1,382.3 |
Cash Generated from/(used in) ... | 3,554.5 |
Direct Taxes Paid | -743.7 |
Total Adjustments(Cash Generat... | -743.7 |
Cash Flow before Extraordinary... | 2,810.8 |
Net Cash from Operating Activi... | 2,810.8 |
Purchased of Fixed Assets | -438.9 |
Sale of Fixed Assets | 331.6 |
Purchase of Investments | -8,897.2 |
Sale of Investments | 7,777.1 |
Interest Received | 87.3 |
Net Cash used in Investing Act... | -2,565.4 |
Proceeds from Issue of shares ... | 33.4 |
Proceed from Short Tem Borrowi... | 352 |
Of Financial Liabilities | -78.5 |
Dividend Paid | -414.6 |
Interest Paid | -134.5 |
Net Cash used in Financing Act... | -242.2 |
Net Profit before Tax and Extr... | 2,223.8 |
Depreciation | 814.3 |
Interest (Net) | -128.9 |
P/L on Sales of Assets | 7.8 |
Prov. and W/O (Net) | 16.3 |
P/L in Forex | -162.3 |
Total Adjustments (PBT and Ext... | 583.1 |
Operating Profit before Workin... | 2,806.9 |
Trade and 0ther Receivables | -865.5 |
Inventories | -528.1 |
Trade Payables | 329.8 |
Total Adjustments (OP before W... | -979.4 |
Cash Generated from/(used in) ... | 1,827.5 |
Direct Taxes Paid | -488.8 |
Total Adjustments(Cash Generat... | -488.8 |
Cash Flow before Extraordinary... | 1,338.7 |
Net Cash from Operating Activi... | 1,338.7 |
Purchased of Fixed Assets | -1,365.6 |
Sale of Fixed Assets | 9.4 |
Purchase of Investments | -9,111.8 |
Sale of Investments | 8,272.6 |
Interest Received | 157.4 |
Net Cash used in Investing Act... | -1,990.1 |
Proceeds from Issue of shares ... | 33.4 |
Proceed from Short Tem Borrowi... | 968.3 |
Of Financial Liabilities | -17.2 |
Dividend Paid | -414.6 |
Interest Paid | -64.4 |
Net Cash used in Financing Act... | 505.5 |
Dr Reddys Laboratories News
Company Details
Registered Office |
|
Address | 8-2-337 Road No 3, Banjara Hills |
City | Hyderabad |
State | Telangana |
Pin Code | 500034 |
Tel. No. | 91-40-49002900 |
Fax. No. | 91-40-49002999 |
shares@drreddys.com | |
Internet | http://www.drreddys.com |
Registrars |
|
Address | 8-2-337 Road No 3 |
City | Hyderabad |
State | Telangana |
Pin Code | 500034 |
Tel. No. | 91-40-49002900 |
Fax. No. | 91-40-49002999 |
shares@drreddys.com | |
Internet | http://www.drreddys.com |
Management |
|
Name | Designation |
G V Prasad | Co-Chairman & Managing Directo |
K Satish Reddy | Chairman |
Kalpana Morparia | Independent Director |
Bruce L A Carter | Independent Director |
Sridar Iyengar | Independent Director |
Shikha Sanjaya Sharma | Independent Director |
Leo Puri | Independent Director |
K P Krishnan | Independent Director |
Pennv Wan | Independent Director |
K Randhir Singh | Company Sec. & Compli. Officer |